Trial Outcomes & Findings for Laser Treatment for Fresh Surgical Scars and Mature Scars (NCT NCT01030198)
NCT ID: NCT01030198
Last Updated: 2020-12-17
Results Overview
The number of participants who experienced improvements in scar appearance, vascularity, height, pliability, pigmentation and any pre-existing pruritis will be counted.
TERMINATED
NA
7 participants
1 month post final treatment (fresh scars) or 3 and 6 months post final treatment (mature scars)
2020-12-17
Participant Flow
Participant milestones
| Measure |
Fresh Surgical Scars
Device: RevLite (Laser Treatment)
|
Mature Scars
Device: RevLite (Laser Treatment)
|
|---|---|---|
|
Overall Study
STARTED
|
0
|
7
|
|
Overall Study
COMPLETED
|
0
|
0
|
|
Overall Study
NOT COMPLETED
|
0
|
7
|
Reasons for withdrawal
| Measure |
Fresh Surgical Scars
Device: RevLite (Laser Treatment)
|
Mature Scars
Device: RevLite (Laser Treatment)
|
|---|---|---|
|
Overall Study
Could not measure efficacy accurately
|
0
|
7
|
Baseline Characteristics
Laser Treatment for Fresh Surgical Scars and Mature Scars
Baseline characteristics by cohort
| Measure |
Fresh Surgical Scars
Treatment of scars
Device: Revlite
|
Mature Scars
n=7 Participants
Treatment of scars
Device: Revlite
|
Total
n=7 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
—
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
—
|
7 Participants
n=4 Participants
|
7 Participants
n=27 Participants
|
|
Age, Categorical
>=65 years
|
—
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
|
Age, Continuous
|
—
|
48.4 years
STANDARD_DEVIATION 10.2 • n=4 Participants
|
48.4 years
STANDARD_DEVIATION 10.2 • n=27 Participants
|
|
Sex: Female, Male
Female
|
—
|
7 Participants
n=4 Participants
|
7 Participants
n=27 Participants
|
|
Sex: Female, Male
Male
|
—
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
|
Region of Enrollment
United States
|
—
|
7 participants
n=4 Participants
|
7 participants
n=27 Participants
|
PRIMARY outcome
Timeframe: 1 month post final treatment (fresh scars) or 3 and 6 months post final treatment (mature scars)Population: Could not measure accurately with measurement tools.
The number of participants who experienced improvements in scar appearance, vascularity, height, pliability, pigmentation and any pre-existing pruritis will be counted.
Outcome measures
Outcome data not reported
Adverse Events
Fresh Surgical Scars
Mature Scars
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee The PI cannot disclose confidential or proprietary information until after it becomes generally known or available to the public.
- Publication restrictions are in place
Restriction type: OTHER